Fam Plann Perspect. 1995 Jan-Feb;27(1):34-6.
Family planning perspectives
J M Westfall, D S Main
PMID: 7720851 Free Article
A comparison of the relative costs of the injectable contraceptive (depot medroxyprogesterone acetate) and the hormonal implant (Norplant) indicates that the implant is a less costly contraceptive option when it is used for its full five-year lifespan. Over a five-year period, the implant costs $107 annually, compared with $140 per year for the injectable. However, if a woman discontinues the implant before she has used it for at least four years, the injectable becomes the less costly option. Relatively high continuation rates--around 95% annually--are necessary to make the implant the more cost-effective contraceptive method.
Keywords: Americas; Comparative Studies; Contraception; Contraception Continuation; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Implants--cost; Contraceptive Methods--cost; Contraceptive Usage; Depo-provera; Developed Countries; Family Planning; Injectables--cost; Levonorgestrel; Medroxyprogesterone Acetate; North America; Northern America; Research Report; Studies; United States
